Protease expression analysis in recently field-isolated strains of Trypanosoma cruzi: A heterogeneous profile of cysteine protease activities between TC I and TC II major phylogenetic groups

Parasitology

Volumn 135, Issue 9, 2008, Pages 1093-1100

  Fampa, P ^a   Lisboa, C V ^a   Jansen, A M ^a   Santos, A L S ^b   Ramirez, M I ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Cruzipain; Host parasite interaction; Proteases; TCI and TCII genotypes; Trypanosoma cruzi; Virulence factors

Indexed keywords

CRUZIPAIN; CYSTEINE PROTEINASE; GELATIN; METALLOPROTEINASE;

ACIDITY; ALKALINITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME RELEASE; HOST PARASITE INTERACTION; HYDROLYSIS; MOLECULAR WEIGHT; NONHUMAN; PARASITE ISOLATION; PHYLOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRYPANOSOMA CRUZI; ZYMOGRAPHY;

ANIMALS; BLOTTING, WESTERN; CYSTEINE ENDOPEPTIDASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENOTYPE; HOST-PARASITE INTERACTIONS; PEPTIDE HYDROLASES; PHYLOGENY; PROTEASE INHIBITORS; TRYPANOSOMA CRUZI;

TRYPANOSOMA CRUZI;

EID: 49549094093     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S0031182008004587     Document Type: Article

References (32)

1. Andrade, S. G. (1999). Trypanosoma cruzi: clonal structure of parasite strain and the importance of principal clones. Memórias do Instituto Oswaldo Cruz 94, 185-187.
2. Aparício, I. M., Scharfstein, J. and Lima, A. P. (2004). A new cruzipain-mediated pathway of human cell invasion by Trypanosoma cruzi requires trypomastigote membranes. Infection and Immunity 72, 5892-5902.
3. Brisse, S., Barnabé, C. and Tibayrenc, M. (2000). Identification of six Trypanosoma cruzi lineages by random amplified polymorphic DNA and multilocus enzyme electrophoresis. International Journal for Parasitology 30, 35-44.
4. Brisse, S., Dujradim, J. C. and Tibayrenc, M. (2000). Identification of six Trypanosoma cruzi lineages by sequence- characterised amplified region markers. Molecular and Biochemical Parasitology 111, 95-105.
5. Buscaglia, C. A. and Di Noia, J. M. (2003). Trypanosoma cruzi clonal diversity and epidemiology of Chagas' Disease. Microbes and Infection 5, 419-427.
6. Campetella, O., Martínez, J. and Cazzulo, J. J. (1990). A major cysteine proteinase regulated in Trypanosoma cruzi. FEMS Microbiology Letters 67, 145-150.
7. Cazzulo, J. J. (2002). Proteinases of Trypanosoma cruzi: potential targets for the chemotherapy of Chagas disease. Current Topics in Medical Chemistry 2, 1261-1271.
8. Cestari, I. S., Evans-Osses, I., Freitas, J. C., Inal, J. M. and Ramirez, M. I. (1998). Mechanism of lectin complement pathway activation by Trypanosoma cruzi. Journal of Infectious Diseases (in the Press).
9. Covarrubias, C., Cortez, M., Ferreira, D. and Yoshida, N. (2007). Interaction with host factors exarcebates Trypanosma cruzi cell capacity upon oral infection. International Journal for Parasitology 37, 1609-1616.
10. Cuevas, I. C., Cazzulo, J. J. and Sanchez, O. (2003). gp63 homologues in Trypanosoma cruzi: surface antigens with metalloprotease activity and a possible role in host cell infection. Infection and Immunity 71, 5739-5749.
11. Di Noia, J. M., Buscaglia, C. A., de Marchi, C. R., Almeida, I. C. and Frasch, A. C. (2002). A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage. Journal of Experimental Medicine 195, 401-413.
12. Dutra, P. M., Couto, L. C., Lopes, A. R. and Meyer-Fernandes, J. R. (2006). Characterization of ecto-phosphatase activities of Trypanosoma cruzi: a comparative study between Colombiana and Y strains. Acta Tropica 100, 88-95.
13. Fernandes, O., Souto, R. P., Castro, J. A., Pereira, J. B., Fernandes, N. C., Junqueira, A. C. V., Naiff, R. D., Barret, T. V., Degrave, W., Campbell, D. A. and Coura, J. R. (1998). Brazilian isolates of Trypanosoma cruzi from humans and triatomines classified into two lineages using mini-exon and ribossomal RNA sequences. American Journal of Tropical Medicine and Hygiene 58, 807-811.
14. Herrera, L., D'Andrea, P. S., Xavier, S. C., Mangia, R. H., Fernándes, O. and Jansen, A. M. (2005). Trypanosoma cruzi infection in wild mammals of the National Park 'Serra da Capivara' and its surroundings (Piauí, Brazil), an area endemic for Chagas disease. Transactions of the Royal Society of Tropical Medicine and Hygiene 99, 379-388.
15. Heussen, C. and Dowdle, E. B. (1980). Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Analytical Biochemistry 102, 196-202.
16. Lisboa, C. V., Mangia, R. H., de Lima, N. R., Martins, A., Dietz, J., Baker, A. J., Ramon-Miranda, C. R., Ferreira, L. F., Fernandes, O. and Jansen, A. M. (2004). Distinct patterns of Trypanosoma cruzi infection in Leontopithecus rosalia in distinct Atlantic coastal rainforest fragments in Rio de Janeiro-Brazil. Parasitology 129, 703-711.
17. Lisboa, C. V., Pinho, A. P., Monteiro, R. V. and Jansen, A. M. (2007). Trypanosma cruzi (kinetoplastida Trypanosomatidae): biological heterogeneity in the isolates derived from wild hosts. Experimental Parasitology 116, 150-155.
18. Lowdes, C. M., Bonaldo, M. C., Thomaz, N. and Goldenberg, S. (1996). Heterogeneity of metalloprotease expression in Trypanosoma cruzi. Parasitology 112, 393-399.
19. Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, J. (1951). Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 139, 265-275.
20. Mathieu-Daudé, F., Bosseno, M. F., Garzon, E., Lelièvre, J., Sereno, D., Ouaissi, A. and Brenière, S. F. (2007). Sequence diversity and differential expression of Tc52 immuno-regulatory protein in Trypanosoma cruzi: potential implications in the biological variability of strains. Parasitology Research 101, 1355-1363.
21. Meirelles, M. N., Juliano, L., Carmona, E., Silva, S. G., Costa, E. M., Murta, A. C. and Scharfstein, J. (1992). Inhibitors of the major cysteinyl proteinase (GP57/51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro. Molecular and Biochemical Parasitology 52, 175-184.
22. Morel, C. M., Deane, M. P. and Gonçalves, A. M. (1986). The complexity of Trypanosoma cruzi populations revealed by schizodeme analysis. Parasitology Today 2, 97-100.
23. O' Connor, O., Bosseno, M. F., Barnabé, C., Douzery, E. J. P. and Brenière, S. F. (2007). Genetic clustering of Trypanosoma cruzi I lineage evidenced by intergenic miniexon gene sequencing. Infection, Genetics and Evolution 7, 587-593.
24. Risso, M. G., Garbarino, G. B., Mocetti, E., Campetella, O., Cappa, S. M. G., Buscaglia, C. A. and Leguizamón, M. S. (2004). Differential expression of a virulence factor, the trans-sialidase, by the main Trypanosoma cruzi phylogenetic lineages. Journal of Infectious Diseases 189, 2250-2259.
25. Ruiz, R. C., Favoreto, S. Jr., Dorta, M. L., Oshiro, M. E., Ferreira, A. T., Manque, P. M. and Yoshida, N. (1998). Infectivity of Trypanosoma cruzi strains is associated with differential expression of surface glycoproteins with differential Ca2+ signalling activity. The Biochemical Journal 330, 505-511.
26. Sajid, M. and McKerrow, J. H. (2002). Cysteine proteases of parasitic organisms. Molecular and Biochemical Parasitology 120, 1-21.
27. Santos, A. L., Branquinha, M. H. and D'Avila-Levy, C. M. (2006). The ubiquitous gp63-like metalloprotease from lower trypanosomatids: in the search for a function. Anais da Academia Brasileira de Ciências 78, 687-714.
28. Secretaria de Vigilância em Saúde, Ministério da Saúde. Doença de Chagas aguda relacionada à ingestão de caldo de cana em Santa Catarina. http://www.anvisa;gov.br/ divulga/noticias/2005/240305_nota.pdf
29. Souto, R. P., Fernandes, O., Macedo, A. M., Campbell, D. A. and Zingales, B. (1996). DNA markers define two major phylogenetic lineages of Trypanosoma cruzi. Molecular and Biochemical Parasitology 83, 141-152.
30. Tibayrenc, M. and Ayala, F. (1988). Isozyme variability in Trypanosoma cruzi, the agent of Chagas' disease: genetical, taxonomical and epidemiological significance. Evolution 42, 277-292.
31. World Health Organization (2005). http://www.who.int/en/
32. Yong, V., Schimtz, V., Vannier-Santos, M. A., Lima, A. P., Lalmanach, G., Juliano, L., Gaultier, F. and Scharfstein, J. (2000). Altered expression of cruzipain and a cathepsin B-like target in a Trypanosoma cruzi cell line displaying resistance to synthetic inhibitors of cysteine-proteinases. Molecular and Biochemical Parasitology 109, 47-59.